Literature DB >> 30592036

Transfusion strategies for major haemorrhage in trauma.

Nicola S Curry1,2, Ross Davenport3.   

Abstract

Trauma is a leading cause of death worldwide in persons under 44 years of age, and uncontrolled haemorrhage is the most common preventable cause of death in this patient group. The transfusion management of trauma haemorrhage is unrecognisable from 20 years ago. Changes in clinical practice have been driven primarily by an increased understanding of the pathophysiology of trauma-induced coagulopathy (TIC), which is associated with poor clinical outcomes, including a 3- to 4-fold increased risk of death. Targeting this coagulopathy alongside changes to surgical and anaesthetic practices (an overarching strategy known as damage control surgery/damage control resuscitation) has led to a significant reduction in mortality rates over the last two decades. This narrative review will discuss the transfusion practices that are currently used for trauma haemorrhage and the evidence that supports these practices.
© 2018 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  major bleeding; transfusion; trauma; trauma induced coagulopathy

Year:  2018        PMID: 30592036     DOI: 10.1111/bjh.15737

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Emergency Blood Transfusion for Trauma and Perioperative Resuscitation: Standard of Care.

Authors:  Heiko Lier; Dietmar Fries
Journal:  Transfus Med Hemother       Date:  2021-10-29       Impact factor: 3.747

Review 2.  Whole Blood, Fixed Ratio, or Goal-Directed Blood Component Therapy for the Initial Resuscitation of Severely Hemorrhaging Trauma Patients: A Narrative Review.

Authors:  Mark Walsh; Ernest E Moore; Hunter B Moore; Scott Thomas; Hau C Kwaan; Jacob Speybroeck; Mathew Marsee; Connor M Bunch; John Stillson; Anthony V Thomas; Annie Grisoli; John Aversa; Daniel Fulkerson; Stefani Vande Lune; Lucas Sjeklocha; Quincy K Tran
Journal:  J Clin Med       Date:  2021-01-17       Impact factor: 4.241

3.  The Calcilytic Drug Calhex-231 Ameliorates Vascular Hyporesponsiveness in Traumatic Hemorrhagic Shock by Inhibiting Oxidative Stress and miR-208a-Mediated Mitochondrial Fission.

Authors:  Yan Lei; Xiaoyong Peng; Yi Hu; Mingying Xue; Tao Li; Liangming Liu; Guangming Yang
Journal:  Oxid Med Cell Longev       Date:  2020-12-03       Impact factor: 6.543

4.  Utility of viscoelastic hemostatic assay to guide hemostatic resuscitation in trauma patients: a systematic review.

Authors:  Zhe Zhu; Yong Yu; Kairui Hong; Mengqin Luo; Yefang Ke
Journal:  World J Emerg Surg       Date:  2022-09-13       Impact factor: 8.165

Review 5.  Hemostatic agents for prehospital hemorrhage control: a narrative review.

Authors:  Henry T Peng
Journal:  Mil Med Res       Date:  2020-03-25

Review 6.  Hemorrhagic Resuscitation Guided by Viscoelastography in Far-Forward Combat and Austere Civilian Environments: Goal-Directed Whole-Blood and Blood-Component Therapy Far from the Trauma Center.

Authors:  James H Lantry; Phillip Mason; Matthew G Logsdon; Connor M Bunch; Ethan E Peck; Ernest E Moore; Hunter B Moore; Matthew D Neal; Scott G Thomas; Rashid Z Khan; Laura Gillespie; Charles Florance; Josh Korzan; Fletcher R Preuss; Dan Mason; Tarek Saleh; Mathew K Marsee; Stefani Vande Lune; Qamarnisa Ayoub; Dietmar Fries; Mark M Walsh
Journal:  J Clin Med       Date:  2022-01-12       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.